Aelis Farma SA (EPA:AELIS)
France · Delayed Price · Currency is EUR 1.000
-0.014 (-1.38%)
Sep 11, 2026, 5:35 PM CET
Aelis Farma Revenue
In the year 2025, Aelis Farma had annual revenue of 2.08M EUR, down -62.53%. Aelis Farma had revenue of 1.19M in the half year ending December 31, 2025, a decrease of -82.14%.
Revenue
2.08M
Revenue Growth
-62.53%
P/S Ratio
6.52
Revenue / Employee
130.25K
Employees
16
Market Cap
13.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.08M | -3.48M | -62.53% |
| Dec 31, 2024 | 5.56M | -6.80M | -54.99% |
| Dec 31, 2023 | 12.36M | 3.99M | 47.75% |
| Dec 31, 2022 | 8.36M | -2.40M | -22.28% |
| Dec 31, 2021 | 10.76M | 9.63M | 846.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 28.60M |
| Nicox | 16.77M |
| Poxel | 7.66M |
| Advicenne | 6.40M |
| Plant Advanced Technologies | 1.65M |
| Aton | 661.00K |
| GenSight Biologics | 652.00K |
| TME Pharma | 27.00K |